BSE - Delayed Quote INR

Dishman Carbogen Amcis Limited (DCAL.BO)

252.25
+7.35
+(3.00%)
At close: May 23 at 3:52:35 PM GMT+5:30
Loading Chart for DCAL.BO
  • Previous Close 244.90
  • Open 247.85
  • Bid 252.25 x --
  • Ask 252.25 x --
  • Day's Range 240.50 - 253.10
  • 52 Week Range 132.75 - 307.80
  • Volume 85,679
  • Avg. Volume 29,528
  • Market Cap (intraday) 39.549B
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) --
  • EPS (TTM) -7.01
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 12, 2019
  • 1y Target Est --

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutical and cosmetic-related products; vitamin D products and its analogues; hand and body wash, sanitizers, and antiseptics; and phase transfer catalysts, soft gel capsules, disinfectant formulations, cholesterol, lanolin-related products, and liquid and lyophilized sterile injectables. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

imdcal.com

1,132

Full Time Employees

March 31

Fiscal Year Ends

Recent News: DCAL.BO

View More

Performance Overview: DCAL.BO

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

DCAL.BO
6.64%
S&P BSE SENSEX (^BSESN)
4.58%

1-Year Return

DCAL.BO
30.19%
S&P BSE SENSEX (^BSESN)
8.36%

3-Year Return

DCAL.BO
112.51%
S&P BSE SENSEX (^BSESN)
50.53%

5-Year Return

DCAL.BO
243.20%
S&P BSE SENSEX (^BSESN)
166.43%

Compare To: DCAL.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DCAL.BO

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    39.55B

  • Enterprise Value

    60.31B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.54

  • Price/Book (mrq)

    0.69

  • Enterprise Value/Revenue

    2.34

  • Enterprise Value/EBITDA

    15.72

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.14%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    26.5B

  • Net Income Avi to Common (ttm)

    -1.1B

  • Diluted EPS (ttm)

    -7.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.16B

  • Total Debt/Equity (mrq)

    43.70%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: DCAL.BO

View More

Company Insights: DCAL.BO

Research Reports: DCAL.BO

View More

People Also Watch